Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Vitae Pharmaceuticals, Inc | Financial_Report.xls |
EX-31.2 - EX-31.2 - Vitae Pharmaceuticals, Inc | a14-23429_1ex31d2.htm |
EX-32.2 - EX-32.2 - Vitae Pharmaceuticals, Inc | a14-23429_1ex32d2.htm |
EX-31.1 - EX-31.1 - Vitae Pharmaceuticals, Inc | a14-23429_1ex31d1.htm |
10-Q - 10-Q - Vitae Pharmaceuticals, Inc | a14-23429_110q.htm |
Exhibit 32.1
Statement of Chief Executive Officer
Pursuant to Section 1350 of Title 18 of the United States Code
Pursuant to Section 1350 of Title 18 of the United States Code as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Jeffrey S. Hatfield, the Chief Executive Officer of Vitae Pharmaceuticals, Inc. (the Company), hereby certifies that based on the undersigneds knowledge:
1) The Companys quarterly report on Form 10-Q for the period ended September 30, 2014 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 12, 2014 |
/s/ JEFFREY S. HATFIELD |
|
Jeffrey S. Hatfield |
|
Chief Executive Officer |
|
(Principal Executive Officer) |